Animal Pharm is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PEOPLE - ImmuCell board makes new appointments:

ImmuCell has appointed Robert Bruce and Dr David Tomsche to serve on its board of directors. ImmuCell, based in Portland, Maine, manufacturers First Defense, which helps prevent scours in calves, and Mast Out, a mastitis treatment for dairy cows to which Pfizer Animal Health purchased the licensing rights earlier this year (Animal Pharm No 600, p 5). Mr Bruce was formerly the chief operating officer and vice-president of Enterix, a company that developed a colorectal cancer-screening device and was later acquired by Quest Diagnostics. He is also the founder, owner, and president of Oakmont Advisory Group, a financial consulting company in Portland. Dr Tomsche co-owns a large dairy operation in the state of Minnesota and co-founded Stearns Veterinary Outlet, a construction supply business and animal health marketer for the dairy industry. He is also a partner and large animal practitioner with Minnesota Veterinary Associates and has experience in the Japanese animal industry.

Advertisement

Topics

What to read next

Advertisement
UsernamePublicRestriction

Register

AP011755

Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel